The insulin-like growth factor (IGF) system is highly conserved across species and plays a critical role in all phases of the mammalian life cycle, from fetal development through childhood / pubertal growth and adulthood. Insulin-like growth factor-1 (IGF-I), an important peptide hormone of the IGF system, is involved in regulation cell cycle - promoting cell proliferation and somatic growth while inhibiting apoptosis - in tissues throughout the body. In humans, the role of the IGF system in aging and age-related diseases is still poorly understood, though this field of research has raised hopes for new drugs that slow the aging process by modulating IGF pathways. The present study will assess the association of circulating levels of IGF-I, IGF-I, and IGF binding proteins (IGFBP-1, IGFBP-2, IGFBP-3) with functional limitation, disability, performance-based tests of physical function, brain morphologic changes, and survival/longevity among older adults. The study will use specimens and data from the Cardiovascular Health Study (CHS) cohort - a large multi-center NIH-funded cohort of n=5,888 community-dwelling men and women 65 years or older, with detailed longitudinal data capturing age-related outcomes. Follow-up in CHS is now over 15 years, which will allow us to go beyond any prior studies by defining within-individual trajectories of IGF-I and IGFBP levels from repeated blood samples, and relating these measurements to age-related outcomes. Further studies will identify genetic determinants of IGF-I and IGFBPs using a whole-genome approach, with replication in the Framingham and Rotterdam cohorts.

Public Health Relevance

The insulin-like growth factor (IGF) system appears to play a major role in the aging process. However, in humans, the role of the IGF system in aging and age-related diseases is still poorly understood. This project will assess the relationship of the IGF system with disability, changes in brain structure, and longevity among 65+ year old men and women, with the long-term goal of informing the development of new drugs that slow the aging process by modulating IGF pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG031890-01A2
Application #
7736534
Study Section
Neurological, Aging and Musculoskeletal Epidemiology (NAME)
Program Officer
Nayfield, Susan G
Project Start
2009-09-30
Project End
2013-08-31
Budget Start
2009-09-30
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$623,702
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Garg, P K; Biggs, M L; Kaplan, R et al. (2018) Fasting and post-glucose load measures of insulin resistance and risk of incident atrial fibrillation: The Cardiovascular Health Study. Nutr Metab Cardiovasc Dis 28:716-721
Kaplan, Robert C; Strizich, Garrett; Aneke-Nash, Chino et al. (2017) Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort. J Clin Endocrinol Metab 102:267-278
Greenlee, Heather; Strizich, Garrett; Lovasi, Gina S et al. (2017) Concordance With Prevention Guidelines and Subsequent Cancer, Cardiovascular Disease, and Mortality: A Longitudinal Study of Older Adults. Am J Epidemiol 186:1168-1179
Aneke-Nash, Chino S; Dominguez-Islas, Clara; B?žková, Petra et al. (2016) Agreement between circulating IGF-I, IGFBP-1 and IGFBP-3 levels measured by current assays versus unavailable assays previously used in epidemiological studies. Growth Horm IGF Res 26:11-6
Willems, Sara M; Cornes, Belinda K; Brody, Jennifer A et al. (2016) Association of the IGF1 gene with fasting insulin levels. Eur J Hum Genet 24:1337-43
Teumer, Alexander; Qi, Qibin; Nethander, Maria et al. (2016) Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits. Aging Cell 15:811-24
Kim, Ryung S; Kaplan, Robert C (2014) Analysis of secondary outcomes in nested case-control study designs. Stat Med 33:4215-26
Sanders, Jason L; Ding, Victoria; Arnold, Alice M et al. (2014) Do changes in circulating biomarkers track with each other and with functional changes in older adults? J Gerontol A Biol Sci Med Sci 69:174-81
Rosenberg, Michael A; Kaplan, Robert C; Siscovick, David S et al. (2014) Genetic variants related to height and risk of atrial fibrillation: the cardiovascular health study. Am J Epidemiol 180:215-22
Wang, Tao; Zhou, Baiyu; Guo, Tingwei et al. (2014) A robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations. Genet Epidemiol 38:162-71

Showing the most recent 10 out of 22 publications